Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: Israel Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20094
20102
20133
20141
20153
20161
20171
20191
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer7
Eli Lilly and Company3
Can-Fite BioPharma2
Merck Sharp & Dohme LLC2
Bristol-Myers Squibb1
Eisai Limited1
Exelixis1
Novartis Pharmaceuticals1
SillaJen, Inc.1
Tiziana Life Sciences LTD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular20
Neoplasms5
Liver Neoplasms4
Carcinoma, Non-Small-Cell Lung2
Ovarian Neoplasms2
Stomach Neoplasms2
Breast Neoplasms1
Carcinoma1
Cholangiocarcinoma1
Endometrial Neoplasms1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.